(Japan)
A pharmacokinetic-pharmacodynamic modeling approach to optimize ethambutol dosage based on in vitro time-kill assay against Mycobacterium avium
(Australia)
Active cycle of breathing technique, oscillating-PEP therapy or walking with huffing during a bronchiectasis exacerbation
(Australia)
The Impact of Nebulised Fucose/Galactose on Pseudomonas aeruginosa Airway Infection
Acknowledgement of Country
Lung Foundation Australia, the University of Queensland and Lena Group acknowledge the Traditional Custodians of the land on which we meet, and recognise their unceded sovereignty of and deep connection to Country.
We respectfully acknowledge the Turrbal people and the Jagera people, on whose lands we have convened for WBC 2025. We pay our respect to their Elders past and present. We do so in the spirit of reconciliation, recognising that Aboriginal and Torres Strait Islander peoples across Australia are significantly overrepresented in lung disease and lung cancer. We are committed to partnering with communities to address this and Close the Gap.
Organising and Sponsors Secretariat:
Lena Corporation S.A.M.
formerly known as Publi Créations S.A.M.
+377 97 97 35 55
wbc@lena.events
Receive updates and news about the congress directly into your inbox
Copyright ©2025 8th WBC | All Rights Reserved | Powered by Lenagroup
We are pleased to share that the abstracts from the 8th World Bronchiectasis Conference will be published on the scientific journal Pulmonary Medicine.
